Advisor Resource Council Edwards Lifesciences Corp Transaction History

Advisor Resource Council

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$61.71 - $77.76 $446,842 - $563,060	7,241 New	7,241 $552,000
Q2 2022 Jul 27, 2022	BUY	$86.5 - $128.27 $700,996 - $1.04 Million	8,104 New	8,104 $770,000
Q1 2022 Apr 20, 2022	SELL	$101.96 - $128.34 $831,381 - $1.05 Million	-8,154 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $867,340 - $1.07 Million	8,154 New	8,154 $1.06 Million
Q3 2021 Nov 16, 2021	SELL	$102.91 - $122.75 $708,123 - $844,642	-6,881 Closed	0 $0
Q2 2021 Aug 19, 2021	BUY	$83.84 - $104.76 $517,125 - $646,159	6,168 Added 865.08%	6,881 $713,000
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $59,777 - $74,693	713 New	713 $73,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

Stay updated on Advisor Resource Council with notifications on news.